My3D® Personalized Pelvic Reconstruction— 510(k) K223348

Name: FDA 510(k) clearance K223348
Creator: U.S. Food and Drug Administration
Published: 2023-01-30

Substantially Equivalent

Onkos Surgical, Inc.

FDA 510(k) clearance K223348 for My3D® Personalized Pelvic Reconstruction, Substantially Equivalent on 2023-01-30. Applicant: Onkos Surgical, Inc.. Device class: 2.

Clearance details

Applicant: Onkos Surgical, Inc.
Product code: Code LPH
Device class: Class 2
Regulation: 21 CFR 888.3358
Advisory panel: Orthopedic
Date received: 2022-11-02
Decision date: 2023-01-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Parsippany, NJ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LPH

view all

K253630 — Mpact 3D Metal Foam2026-08-28
K254043 — TRIVANCE Hip Stem2026-08-04
K261624 — Omnifit® 20° Series I Insert +11 more2026-07-10
K243192 — iNSitu Lateralized Acetabular Liners, iNSitu Femoral Stems with Plasma Sprayed CPTi Coating2026-06-05
K251270 — Taperloc® Complete Hip Stem2026-05-19

More clearances from Onkos Surgical, Inc.

view all

K253066 — ELEOS with NanoCept® Technology Limb Salvage System2026-06-08
K252920 — ELEOS Limb Salvage System with NanoCept® Technology2025-10-15
K180130 — ELEOS Bipolar Acetabular System2018-02-23
K161520 — ELEOS Limb Salvage System2016-10-28

Adverse events under product code LPH

product code LPH

Death: 73
Injury: 31,640
Malfunction: 3,358
Other: 2
Total: 35,073

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.